EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clearance of senescent cells by navitoclax (ABT263) rejuvenates UHMWPE-induced osteolysis

Weiping Su, Yihe Hu, Xiaolei Fan, Jie Xie

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.109694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Weiping Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The 3rd Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Osteolysis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periprosthetic osteolysis is the leading cause of prosthesis failure and subsequent total joint revision. Wear particles produced by prosthetic materials are the main biological factors that cause periprosthetic osteolysis. Reducing the inflammatory response induced by the phagocytosis of wear particles by macrophages, blocking the activation of osteoclastogenesis, and promoting bone regeneration are essential for preventing the aseptic loosening of prostheses. In this study, we demonstrated that cellular senescence played a vital role during the process of ultra-high molecular weight polyethylene (UHMWPE) particle-induced osteolysis. Administration of the senolytic drug navitoclax (ABT263) could eliminate senescent cells and inhibit the secretion and inflammatory state of the senescence-associated secretory phenotype (SASP). We also discovered that ABT263 inhibited the formation of osteoclasts and had a significant therapeutic effect on UHMWPE particle-induced osteolysis based on the results of UHMWPE-induced mouse cranial osteolysis. Therefore, our research provided innovative strategies and ideas for the prevention and treatment of periprosthetic osteolysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteolysisAnimalsMicePolyethylenesOsteoclastsCellular SenescenceAniline CompoundsSulfonamides

Stichwörter der Autor:innen

ABT-263Cellular senescenceMacrophageOsteolysisUHMWPE

Substanzen

Polyethylenesultra-high molecular weight polyethylenenavitoclaxAniline CompoundsSulfonamides

Autor:innen und Institutionen

  • Department of Orthopedics, The 3rd Xiangya Hospital, Central South University, Changsha, China.
  • Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Orthopedics, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China; Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China. Electronic address: fanxl_2011@163.com.
  • Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: dr_xiejie@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Su, W., Hu, Y., Fan, X., & Xie, J. (2023). Clearance of senescent cells by navitoclax (ABT263) rejuvenates UHMWPE-induced osteolysis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.109694

Vancouver

Su W, Hu Y, Fan X, Xie J. Clearance of senescent cells by navitoclax (ABT263) rejuvenates UHMWPE-induced osteolysis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.109694

BibTeX
@article{Su2023,
  author = {Su, Weiping and Hu, Yihe and Fan, Xiaolei and Xie, Jie},
  title = {Clearance of senescent cells by navitoclax (ABT263) rejuvenates UHMWPE-induced osteolysis},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.109694}
}
Kostenlos starten →